The role of dietary sugars, overweight, and obesity in type 2 diabetes mellitus: a narrative review.


Journal

European journal of clinical nutrition
ISSN: 1476-5640
Titre abrégé: Eur J Clin Nutr
Pays: England
ID NLM: 8804070

Informations de publication

Date de publication:
11 2022
Historique:
received: 30 11 2021
accepted: 25 02 2022
revised: 18 02 2022
pubmed: 23 3 2022
medline: 5 11 2022
entrez: 22 3 2022
Statut: ppublish

Résumé

Nowadays, there is still a popular belief that dietary sugars, in particular sucrose, are directly linked to the development of type 2 diabetes mellitus (T2DM). Furthermore, since insulin action is impaired in T2DM, it is still believed that excluding dietary sugars from the diet can adequately treat T2DM. This might be based on the assumption that dietary sugars have a stronger impact on blood glucose levels than other carbohydrates. Therefore, the aim of this review is to discuss the effects of dietary sugars intake, including sugar-sweetened beverages (SSBs) against the background of overall energy intake and weight gain in the development of T2DM. Furthermore, the effect of dietary sugars, including SSBs on glycemic control will be discussed. Results from various systematic reviews and meta-analyses do not support the idea that the intake of sucrose and other dietary sugars is linked to T2DM. Long-chain or complex carbohydrates can have a greater impact on postprandial glycemic response than sucrose. SSBs do not affect glycemic control if substituted for other calorie sources. Current scientific evidence clearly points toward excess energy intake followed by excess body fat gain being most relevant in the development of T2DM.

Identifiants

pubmed: 35314768
doi: 10.1038/s41430-022-01114-5
pii: 10.1038/s41430-022-01114-5
pmc: PMC9630103
doi:

Substances chimiques

Dietary Sugars 0
Sucrose 57-50-1
Dietary Sucrose 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1497-1501

Informations de copyright

© 2022. The Author(s).

Références

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD006296
pubmed: 19160276
PLoS One. 2018 Mar 20;13(3):e0194127
pubmed: 29558518
Diabet Med. 1988 Oct;5(7):676-80
pubmed: 2975554
Diabetes Care. 2007 Mar;30(3):510-5
pubmed: 17327313
Diabetes Care. 2013 Dec;36(12):4166-71
pubmed: 24265366
Diabetes. 2005 Mar;54(3):603-8
pubmed: 15734833
Can J Diabetes. 2016 Aug;40(4):282-6
pubmed: 27216628
Am J Clin Nutr. 2019 Oct 1;110(4):803-804
pubmed: 31504123
Am J Clin Nutr. 1995 Jul;62(1 Suppl):212S-221S; discussion 221S-227S
pubmed: 7598079
Eur J Clin Nutr. 2007 Dec;61 Suppl 1:S122-31
pubmed: 17992183
Diabetologia. 1986 Apr;29(4):216-20
pubmed: 3710013
Nutrients. 2019 Jun 05;11(6):
pubmed: 31195724
BMJ. 2019 Jul 03;366:l2368
pubmed: 31270064
J Pediatr Gastroenterol Nutr. 2017 Dec;65(6):681-696
pubmed: 28922262
Lancet. 2022 Jan 22;399(10322):394-405
pubmed: 34600604
Am J Med. 1988 Feb;84(2):193-200
pubmed: 3044068
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
Nutrients. 2019 Nov 01;11(11):
pubmed: 31683759
BMJ. 2018 Nov 21;363:k4644
pubmed: 30463844
Am J Clin Nutr. 2020 Jan 1;111(1):187-196
pubmed: 31711109
Metabolism. 2015 Feb;64(2):338-47
pubmed: 25467842
BMJ. 2021 Aug 4;374:n1651
pubmed: 34348965
BMJ. 2012 Jan 15;346:e7492
pubmed: 23321486
CMAJ. 2017 May 23;189(20):E711-E720
pubmed: 28536126
Nat Rev Dis Primers. 2015 Jul 23;1:15019
pubmed: 27189025
N Engl J Med. 2001 Sep 13;345(11):790-7
pubmed: 11556298
J Acad Nutr Diet. 2015 Sep;115(9):1447-63
pubmed: 25935570
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Nutrients. 2018 Sep 22;10(10):
pubmed: 30249012
N Engl J Med. 2014 Sep 18;371(12):1131-41
pubmed: 25229917
Diabetologia. 2022 Jan;65(1):14-36
pubmed: 34796367
Nutrients. 2020 Feb 19;12(2):
pubmed: 32093020
Physiol Rev. 2010 Jan;90(1):23-46
pubmed: 20086073
Am J Clin Nutr. 2021 Nov 8;114(5):1625-1632
pubmed: 34258626
Diabetologia. 2011 Oct;54(10):2506-14
pubmed: 21656330
Obesity (Silver Spring). 2012 Sep;20(9):1844-50
pubmed: 21720441
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Endocrinol Metab Clin North Am. 2008 Sep;37(3):635-46, viii-ix
pubmed: 18775356
J Intern Med. 2016 Nov;280(5):465-475
pubmed: 27699898
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Am J Clin Nutr. 2012 Mar;95(3):587-93
pubmed: 22258267
Diabet Med. 2020 Apr;37(4):681-688
pubmed: 31479535
Eur J Clin Nutr. 1998 Dec;52(12):924-8
pubmed: 9881888
Diabetes Care. 1996 Nov;19(11):1249-56
pubmed: 8908389
Eur J Nutr. 2016 Nov;55(Suppl 2):25-43
pubmed: 27900447
Am J Clin Nutr. 2002 Jul;76(1):290S-8S
pubmed: 12081854
Am J Clin Nutr. 1981 Mar;34(3):362-6
pubmed: 6259925
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8236-40
pubmed: 22547801
Diabetologia. 2002 Sep;45(9):1201-10
pubmed: 12242452
Am J Clin Nutr. 2009 Jan;89(1):97-105
pubmed: 19056599

Auteurs

Meike Veit (M)

Department Consumer Protection-Nutrition Policy-Sustainability Europe, Pfeifer & Langen GmbH & Co. KG, Cologne, Germany.

Renske van Asten (R)

Knowledge Centre Sugar & Nutrition, Hilversum, The Netherlands.

Andries Olie (A)

Board Members, Knowledge Centre Sugar & Nutrition, Hilversum, The Netherlands.
Royal Cosun, Breda, The Netherlands.

Philip Prinz (P)

Department of Nutritional Sciences, German Sugar Association, Berlin, Germany. prinz@zuckerverbaende.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH